-
1 Comment
BrightGene Bio-Medical Technology Co., Ltd is currently in a long term downtrend where the price is trading 17.1% below its 200 day moving average.
From a valuation standpoint, the stock is 128.4% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 22.0.
BrightGene Bio-Medical Technology Co., Ltd's total revenue rose by 44.9% to $275M since the same quarter in the previous year.
Its net income has increased by 1.8% to $48M since the same quarter in the previous year.
Based on the above factors, BrightGene Bio-Medical Technology Co., Ltd gets an overall score of 2/5.
| Sector | Healthcare |
|---|---|
| ISIN | CNE100003PR1 |
| Exchange | SHG |
| CurrencyCode | CNY |
| Industry | Biotechnology |
| Market Cap | 23B |
|---|---|
| Beta | 0.08 |
| PE Ratio | 223.21 |
| Target Price | 44.21 |
| Dividend Yield | 0.2% |
BrightGene Bio-Medical Technology Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products in China and internationally. The company offers BGM0504 injection which is in Phase III clinical trial for diabetes and weight loss; and BGM1812, a long-acting amylin analog in preclinical development. It also provides formulations, preparation products; active pharmaceutical ingredients and intermediates; and veterinary drugs for various therapeutic areas, including antitumor, antibodies drug conjugate, anti-infection, angiography, gynecology, cardiovascular, cerebrovascular, iron supplement, digestion, respiratory, and immunosuppression. In addition, the company is involved in technology research, development, and transfer of biomedical products; import and export of medicines; and production and operation of medical devices; and technical services. BrightGene Bio-Medical Technology Co., Ltd. was founded in 2001 and is based in Suzhou, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 688166.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
